Oops. I thought that was the one issue he was solid on.
Well, a Google search suggests that Novo Nordisk is a regular pharmaceutical company with many diabetic customers. I really don’t have much medical terminology expertise, so I can’t decipher the technical stuff, but embryonic stem-cell research may comprise only a minor part of their operations.